 |
| 25-Jan-10 09:55AM | Earnings Surprises For Diagnostics Companies Creates Good Stock Price Entry Point For New Investors According To Industry Expert Wall Street Transcript |
| 10-Dec-09 04:13PM | ACURA PHARMACEUTICALS, INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online -11.34% |
| 30-Oct-09 09:04AM | ACURA PHARMACEUTICALS, INC Financials EDGAR Online Financials |
| 26-Oct-09 04:10PM | Acura Pharmaceuticals Reports Third Quarter 2009 Financial Results GlobeNewswire |
| 22-Sep-09 03:40PM | Fearful Stocks for Greedy Investors at Motley Fool |
| 04-Sep-09 10:11AM | King, Acura say FDA does not need new Acurox trial AP |
| 03-Sep-09 06:08PM | UPDATE - Acura says no new trials required for pain drug now at Reuters |
| 05:19PM | ACURA PHARMACEUTICALS, INC Files SEC form 8-K, Other Events EDGAR Online |
| 05:08PM | InPlay: Acura Pharma and King Pharmaceuticals Provide Update on Acurox NDA Briefing.com |
| 05:07PM | Acura Pharmaceuticals and King Pharmaceuticals Provide Update on Acurox NDA Business Wire |
| 06-Aug-09 07:01AM | ACURA PHARMACEUTICALS, INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online |
| 07:00AM | Acura Pharmaceuticals Submits Acurox(R) Briefing Package to FDA GlobeNewswire |
| 01-Aug-09 09:20AM | New Star Analyst Rankings for Acura Pharmaceuticals, Inc. StarMine |
| 30-Jul-09 04:11PM | ACURA PHARMACEUTICALS, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an EDGAR Online |
| 04:10PM | Acura Pharmaceuticals Reports Second Quarter 2009 Financial Results GlobeNewswire |
| 07-Jul-09 09:57AM | UPDATE - King, Pain Therapeutics may refile Remoxy in 2010 at Reuters |
| 02-Jul-09 11:07AM | UPDATE - FDA denies approval of King, Acura's pain drug at Reuters |
| 09:13AM | ADC Telecommunications, Energy Conversion Devices and Acorda Therapeutics lead small-cap volume in pre-market SmallCapInvestor.com |
| 07:58AM | UPDATE - FDA denies to approve King, Acura's pain drug at Reuters |
| 07:31AM | ACURA PHARMACEUTICALS, INC Files SEC form 8-K, Other Events EDGAR Online |
| 07:10AM | Acura, King get FDA response on Acurox at MarketWatch |
| 07:00AM | Acura and King Receive FDA Complete Response Letter Regarding Acurox(R) PR Newswire |
| 25-Jun-09 04:05PM | ACURA PHARMACEUTICALS, INC Files SEC form 8-K, Change in Directors or Principal Officers, Amendments to Articles of I EDGAR Online |
| 24-Jun-09 12:27AM | [$$] Russell 2000 Starts Week With 4.5% Drop at The Wall Street Journal Online |
| 23-Jun-09 12:45PM | Biotech Stocks: Drug stocks edge higher; Matrixx tumbles at MarketWatch -22.19% |
| 12:20PM | UPDATE - Acura says pain drug to miss June 30 approval date at Reuters |
| 11:40AM | Acura Pharmaceuticals, Halozyme Therapeutics and Actuant lead small-cap percentage losers SmallCapInvestor.com |
| 10:46AM | Acura shares tank on FDA woes at MarketWatch |
| 09:59AM | UPDATE - Acura says pain drug to miss June 30 approval date at Reuters |
| 09:24AM | Halozyme Therapeutics, Smith & Wesson Holding and Century Aluminum lead small-cap volume in pre-market SmallCapInvestor.com |
| 08:50AM | Acura Pharmaceuticals Receives Preliminary Review Letter from FDA Regarding Acurox(r) GlobeNewswire |
| 12-May-09 02:31AM | FDA Calendar Updates: Royal Returns for King Pharma at Seeking Alpha |
| 01-May-09 07:00AM | ACURA PHARMACEUTICALS, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an EDGAR Online |
| 07:00AM | Acura Pharmaceuticals Reports First Quarter 2009 Financial Results GlobeNewswire |
| 26-Mar-09 09:24AM | ACURA PHARMACEUTICALS, INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online |
| 07:00AM | Acura Pharmaceuticals, Inc. Names Garth Boehm, Ph.D. VP of Modified Release Dosage Form Development GlobeNewswire |
| 12-Mar-09 04:38PM | TSC Ratings' Updates: Intuit at TheStreet.com |
| 11-Mar-09 04:00PM | Acura Pharmaceuticals to Present At Cowen and Company Health Care Conference GlobeNewswire +8.19% |
| 03-Mar-09 04:22PM | Seeking Gain From Pain at Motley Fool |
| 04:22PM | Seeking Gain From Pain at Motley Fool |
| 04:02PM | ACURA PHARMACEUTICALS, INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Finan EDGAR Online |
| 10:58AM | FDA to review immediate release pain drug Acurox AP |
| 08:01AM | UPDATE - King, Acura pain drug gets priority review at Reuters |
| 07:00AM | Acurox(r) Tablets New Drug Application Accepted for Filing With a Priority Review Classification GlobeNewswire |
| 02-Mar-09 07:00AM | ACURA PHARMACEUTICALS, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an EDGAR Online -9.81% |
| 07:00AM | Acura Pharmaceuticals Reports Year-End and Fourth Quarter 2008 Financial Results GlobeNewswire |
| 09-Feb-09 09:36AM | ACURA PHARMACEUTICALS, INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online |
| 07:00AM | Acura Pharmaceuticals, Inc. Names Albert W. Brzeczko, Ph.D. VP, Technical Affairs GlobeNewswire |
| 02-Jan-09 09:03AM | ACURA PHARMACEUTICALS, INC Files SEC form 8-K, Other Events EDGAR Online |
| 07:00AM | New Drug Application Submitted For Acurox(r) Tablets GlobeNewswire |
| 24-Dec-08 07:23AM | Acura gets $3 million under King licensing deal AP +5.67% |
| 07:17AM | ACURA PHARMACEUTICALS, INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online |
| 07:00AM | King Pharmaceuticals Exercises Option to License Fourth Opioid Product From Acura Pharmaceuticals GlobeNewswire |
| 18-Dec-08 08:01AM | ACURA PHARMACEUTICALS, INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online +7.09% |
| 19-Nov-08 02:16PM | A 1-in-100 Investor at Motley Fool |
| 14-Nov-08 05:02PM | Russell tanks 7%; FNDT, ACUR and MYRG lead gainers SmallCapInvestor.com +16.32% |
| 04:28PM | Five-year weekly closing low for Russell as techs slump, retailers swoon SmallCapInvestor.com |
| 27-Oct-08 05:19PM | Acura Pharmaceuticals, Inc. Reports Third Quarter 2008 Financial Results GlobeNewswire -8.27% |
| 04:54PM | ACURA PHARMACEUTICALS, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an EDGAR Online |
| 14-Oct-08 08:02AM | ACURA PHARMACEUTICALS, INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online |
| 13-Oct-08 08:00AM | Acura Pharmaceuticals and King Pharmaceuticals Announce Positive Top Line Results of Key Clinical Study Assessing Abuse Liability GlobeNewswire +5.95% |
| 10-Oct-08 12:32PM | Acura Pharmaceuticals, Inc. to Present At Natixis Bleichroeder Hidden Gems Conference GlobeNewswire -7.19% |
| 02-Oct-08 01:37PM | PetMed Delivers at Investopedia |
| 19-Sep-08 04:10PM | 10 Stocks Under Attack at Motley Fool |
| 02-Sep-08 08:31AM | ACURA PHARMACEUTICALS, INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online |
| 08:00AM | Acura Pharmaceuticals, Inc. Announces Return of President and CEO From Medical Leave GlobeNewswire |
| 25-Aug-08 03:47PM | King Triples Down at Motley Fool |
| 22-Aug-08 05:47PM | Pharma Deals: Start Hostile. Get Friendly. at The Wall Street Journal Online |
| 09:09AM | UPDATE - King offers to buy Alpharma for $1.4 billion at Reuters |
| 30-Jul-08 04:05PM | Acura Pharmaceuticals, Inc. Reports Second Quarter 2008 Financial Results GlobeNewswire |
| 04:02PM | ACURA PHARMACEUTICALS, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an EDGAR Online |
| 23-Jul-08 09:51AM | Acura' Acurox: A Revenue Deterrent Formulation of Oxycodone at Seeking Alpha |
| 22-Jul-08 06:20AM | Acura Pharmaceuticals: To the rescue SmallCapInvestor.com |
| 21-Jul-08 09:42AM | ACURA PHARMACEUTICALS, INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online |
| 08:00AM | Acura Pharmaceuticals, Inc. Announces Action Regarding Notice of Allowance Received for Second Aversion Technology Patent GlobeNewswire |
| 10-Jul-08 04:07PM | ACURA PHARMACEUTICALS, INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Ex EDGAR Online |
| 02-Jul-08 04:48PM | New day, same crude story SmallCapInvestor.com -16.90% |
| 30-Jun-08 02:16PM | Russell 2000 adds 53 health care companies AP -11.67% |
| 01:55PM | Acura Pharma gets $5 million fee from King Pharma AP |
| 12:07PM | MGIC Investment, BancTrust Financial Group and Atlantic Southern Financial Group lead small-cap percentage losers SmallCapInvestor.com |
| 08:11AM | ACURA PHARMACEUTICALS, INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online |
| 08:00AM | Acura Pharmaceuticals, Inc. Added to the Russell 3000 Index and the Russell Microcap Index PrimeNewswire |
| 08:00AM | Acura Pharmaceuticals, Inc. Receives $5.0 Million Milestone Payment PrimeNewswire |
| 17-Jun-08 10:52AM | Acura pain pill meets goal in late-stage trial AP +5.19% |
| 09:16AM | UPDATE - King, Acura pain drug hits goal in late-stage trial at Reuters |
| 08:06AM | ACURA PHARMACEUTICALS, INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online |
| 08:00AM | Acurox Tablets Meet Primary Endpoint in Pivotal Phase III Study PrimeNewswire |
| 04-Jun-08 01:21PM | ACURA PHARMACEUTICALS, INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online |
| 03-Jun-08 04:05PM | Acura Pharmaceuticals, Inc. Announces Notice of Allowance for Second Aversion Technology Patent PrimeNewswire |
| 02-Jun-08 04:33PM | ACURA PHARMACEUTICALS, INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online -8.43% |
| 04:05PM | Acura Pharmaceuticals, Inc. Announces Active IND for Second Opioid Analgesic Product Candidate Using Aversion Technology PrimeNewswire |
| 10:17AM | Small caps sink as credit crunch worries overcome data SmallCapInvestor.com |
| 28-May-08 03:54PM | King Pays a Modest Ransom at Motley Fool |
| 27-May-08 04:03PM | ACURA PHARMACEUTICALS, INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online |
| 09:16AM | King pays Acura $3M for product license AP |
| 08:00AM | King Pharmaceuticals Exercises Option to License Third Opioid Product Utilizing Acura's AVERSION Technology PrimeNewswire |
| 30-Apr-08 04:05PM | Acura Pharmaceuticals, Inc. Reports First Quarter 2008 Financial Results PrimeNewswire +7.39% |
| 04:02PM | ACURA PHARMACEUTICALS, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an EDGAR Online |
| 24-Apr-08 09:04AM | ACURA PHARMACEUTICALS, INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online |
| 08:00AM | King Pharmaceuticals and Acura Pharmaceuticals Announce Completion of Patient Enrollment for Pivotal Phase III Clinical Trial Evaluating ACUROX(TM) Business Wire |
|
|
| Acura Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and manufacture of Aversion Technology related product candidates. The company's Aversion Technology acts as a platform for developing multiple opioid analgesic products candidates containing codeine, propoxyphene, morphine, hydrocodone, oxycodone, tramadol, and various other opioid analgesics. Its opioid analgesic products are used to relieve pain, as well as to discourage common methods of pharmaceutical product misuse and abuse, including intravenous injection of dissolved tablets or capsules; nasal snorting of crushed tablets or capsules; and intentional swallowing of excess quantities of tablets or capsules. The company has a license, development, and commercialization agreement with King Pharmaceuticals Research and Development, Inc. to develop and commercialize opioid analgesic products, including Acurox tablets, an orally administered immediate release tablet containing oxycodone HCl; Acuracet tablets containing oxycodone HCl/niacin/APAP; and Vycavert tablets containing hydrocodone bitartrate/niacin/APAP utilizing the Aversion Technology in the United States, Canada, and Mexico. Acura Pharmaceuticals, Inc. was founded in 1935 and is based in Palatine, Illinois. |
|
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| REDDICK ANDREW D | President and CEO | Nov 24 | Option Exercise | 1.30 | 425,000 | 552,500 | 1,335,000 | Nov 25 03:58 PM | | Markham Richard J | Director | May 26 | Sale | 7.38 | 10,000 | 73,800 | 10,923 | May 27 01:23 PM | | CARE CAPITAL II LLC | 10% Owner | May 26 | Sale | 7.38 | 10,000 | 73,800 | 10,923 | May 27 01:31 PM | | CARE CAPITAL II LLC | 10% Owner | May 22 | Sale | 7.50 | 5,800 | 43,500 | 20,923 | May 27 01:31 PM | | Markham Richard J | Director | May 22 | Sale | 7.50 | 5,800 | 43,500 | 20,923 | May 27 01:23 PM | | CARE CAPITAL II LLC | 10% Owner | May 20 | Sale | 7.34 | 6,000 | 44,040 | 26,723 | May 22 12:57 PM | | Markham Richard J | Director | May 20 | Sale | 7.34 | 6,000 | 44,040 | 26,723 | May 22 12:56 PM | | CARE CAPITAL II LLC | 10% Owner | May 15 | Sale | 7.04 | 1,338 | 9,420 | 32,723 | May 19 10:14 AM | | Markham Richard J | Director | May 15 | Sale | 7.04 | 1,338 | 9,420 | 32,723 | May 19 10:14 AM | | Markham Richard J | Director | May 13 | Sale | 7.05 | 7,028 | 49,547 | 34,061 | May 14 01:31 PM | | CARE CAPITAL II LLC | 10% Owner | May 13 | Sale | 7.05 | 7,028 | 49,547 | 34,061 | May 14 01:29 PM | | CARE CAPITAL II LLC | 10% Owner | May 08 | Sale | 6.93 | 10,600 | 73,458 | 41,089 | May 11 04:45 PM | | Markham Richard J | Director | May 08 | Sale | 6.93 | 10,600 | 73,458 | 41,089 | May 11 04:48 PM | | Markham Richard J | Director | May 07 | Sale | 6.91 | 12,900 | 89,139 | 51,689 | May 11 04:48 PM | | CARE CAPITAL II LLC | 10% Owner | May 07 | Sale | 6.91 | 12,900 | 89,139 | 51,689 | May 11 04:45 PM | | Markham Richard J | Director | May 06 | Sale | 6.79 | 12,100 | 82,159 | 64,589 | May 08 08:55 PM | | CARE CAPITAL II LLC | 10% Owner | May 06 | Sale | 6.79 | 12,100 | 82,159 | 64,589 | May 08 08:52 PM | | CARE CAPITAL II LLC | 10% Owner | Mar 24 | Sale | 7.11 | 35,000 | 248,850 | 76,689 | Mar 26 09:49 PM | | Markham Richard J | Director | Mar 24 | Sale | 7.11 | 35,000 | 248,850 | 76,689 | Mar 26 08:08 PM |
|
|
|
|
|
|
